Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis

NCT04517669 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04517669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04517669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 17, 2021
Completion date
July 30, 2024
Enrollment
116 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis